Search results
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoParticipants Charles F. Wagner; Executive VP & CFO; Vertex Pharmaceuticals Incorporated Reshma Kewalramani; CEO, President & Director; Vertex Pharmaceuticals ...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 3 days agoStrategic Acquisition: Announced the acquisition of Alpine Immune Sciences, enhancing the pipeline...
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Reuters via AOL· 3 days ago(Reuters) -Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday,...
Vertex shares eise on earnings beat
Investing.com· 4 days agoVertex Pharmaceuticals (NASDAQ: VRTX ) Incorporated ( NASDAQ : VRTX) reported a robust first quarter for 2024, surpassing analyst expectations with a 13%...
Vertex Energy: Q1 Earnings Snapshot
The Longview News-Journal· 12 hours agoHOUSTON (AP) — HOUSTON (AP) — Vertex Energy Inc. (VTNR) on Thursday reported a loss of $17.7 million in its first quarter.
Vertex Energy: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 12 hours agoHOUSTON (AP) — HOUSTON (AP) — Vertex Energy Inc. (VTNR) on Thursday reported a loss of $17.7 million in its first quarter. On a per-share basis, the Houston-based company ...
Fisher Asset Management LLC Purchases 108 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 3 days agoFisher Asset Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.4% during the 4th quarter, according to the company ...
Vertex Energy: Q1 Earnings Snapshot
San Antonio Express-News· 12 hours agoHOUSTON (AP) — HOUSTON (AP) — Vertex Energy Inc. (VTNR) on Thursday reported a loss...
Vertex Pharmaceuticals (NASDAQ:VRTX) Raised to “Strong-Buy” at StockNews.com
ETF DAILY NEWS· 4 days agoBarclays raised their price objective on shares of Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an overweight rating in a research report on Tuesday, ...
Analyst Report: Royalty Pharma plc
Morningstar Research via Yahoo Finance· 3 hours agoThe firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including ...
